Access cutting-edge i cannot determine the primary condition from the provided information. the only condition listed is "genetic:afamitresgene autoleucel" which appears to be a treatment designation rather than a medical condition, and there are no keywords or meaningful summary details provided to identify what condition this pediatric study is actually treating. treatment through this clinical trial at a research site in Seattle. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Seattle location
Access i cannot determine the primary condition from the provided information. the only condition listed is "genetic:afamitresgene autoleucel" which appears to be a treatment designation rather than a medical condition, and there are no keywords or meaningful summary details provided to identify what condition this pediatric study is actually treating. specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related i cannot determine the primary condition from the provided information. the only condition listed is "genetic:afamitresgene autoleucel" which appears to be a treatment designation rather than a medical condition, and there are no keywords or meaningful summary details provided to identify what condition this pediatric study is actually treating. treatment provided free
Check if you qualify for this i cannot determine the primary condition from the provided information. the only condition listed is "genetic:afamitresgene autoleucel" which appears to be a treatment designation rather than a medical condition, and there are no keywords or meaningful summary details provided to identify what condition this pediatric study is actually treating. clinical trial in Seattle, WA
No-Cost Study Care
Local to Seattle
Convenient for WA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This is a pediatric basket study to investigate the safety and efficacy of afamitresgene autoleucel in HLA-A\*02 eligible and MAGE-A4 positive subjects aged 2-17 years of age with advanced cancers.
Sponsor: Adaptimmune
Yes, this clinical trial (NCT05642455) has an active research site in Seattle, WA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for i cannot determine the primary condition from the provided information. the only condition listed is "genetic:afamitresgene autoleucel" which appears to be a treatment designation rather than a medical condition, and there are no keywords or meaningful summary details provided to identify what condition this pediatric study is actually treating. treatment options in Seattle, WA, this clinical trial (NCT05642455) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Seattle research site is actively enrolling participants for this clinical trial. You'll receive care from experienced i cannot determine the primary condition from the provided information. the only condition listed is "genetic:afamitresgene autoleucel" which appears to be a treatment designation rather than a medical condition, and there are no keywords or meaningful summary details provided to identify what condition this pediatric study is actually treating. specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all i cannot determine the primary condition from the provided information. the only condition listed is "genetic:afamitresgene autoleucel" which appears to be a treatment designation rather than a medical condition, and there are no keywords or meaningful summary details provided to identify what condition this pediatric study is actually treating. clinical trials near you to find additional studies recruiting in your area.
See all leukemia clinical trials recruiting in Seattle — not just this study.
Browse Leukemia Trials in Seattle →